Approved Study Database
Ref. No. | Scientific Title | Principal investigator |
---|---|---|
2008.513 | An International, Multicenter, Randomized, Double-blind Study of Vorinostat (MK-0683) or Placebo in Combination with Bortezomib in Patients with Multiple Myeloma | Prof Cheng Gregory |
2008.512 | A Phase II Single Arm, Multi-Centre Study of Bevacizumab (Avastin_) Pre- and Post- Transarterial Chemoembolisation (TACE) Treatment for Localised Unresectable Hepatocellular Carcinoma (HCC) | Prof. Lai Bo San Paul |
2008.511 | Trabeculectomy with Adjunctive Intra-Vitreal Injection of Bevacizumab(AVASTIN). A Preliminary Study. | Professor Lam Dennis Shun Chiu |
2008.510 | Phaco-Trabeculectomy with Adjunctive Intra-Vitreal Injection of Bevacizumab (Avastin). A Preliminary Study. | Professor Lam Dennis Shun Chiu |
2008.509 | Needling with Adjunctive Intra-Vitreal Injection of Bevacizumab (AVASTIN). A Preliminary Study. | Professor Lam Dennis Shun Chiu |
2008.508 | A Phase 3, Open-label Study to Determine the Long-term Safety and Efficacy of Vedolizumab MLN0002 in Patients with Ulcerative Colitis and Crohn | Prof Sung Joseph |
2008.507 | A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction and Maintenance of Clinical Response and Remission by Vedolizumab MLN0002 in Patients with Moderate to Severe Crohn | Prof Sung Joseph |
2008.506 | A Multicenter, Randomized, Double Blind, Sham Control, Parallel Arm Trial to Assess Effectiveness and Safety of the Ischemic Stroke System ISS, as an Adjunct to Standard of Care in Subjects with Acute Ischemic Stroke | Assistant Professor LEUNG Thomas Wai Hong |
2008.505 | A Multi-center, Double-blind, Randomized, Parallel Group, Placebo-controlled 12-week Study to Investigate Glycemic Parameters of Efficacy, Safety/Tolerability and Pharmacokinetics of Five Dose Levels of RO4998452 in Patients with Type 2 Diabetes Mellitus | Prof. Brian Tomlinson |
2008.503 | Predictors of Antihypertensive Response to Bisoprolol and Hydrocholorothiazide: An Open-labelled, Placebo-controlled Crossover Study to Investigate the Genetic and Biomedical Predictors of Blood Pressure Response in Chinese Patients with Mild to Moderate Hypertension | Professor Tomlinson Brian |
2008.502 | Hormonal Responses to Whole Body Vibration Exercise with Different Vibration Protocols in Elderly Individuals: A Randomized Cross-Over Trial | Mr Tam Tsz King Bjorn |
2008.497 | Prospective Data-Collection for assessment on Efficacy of Invasive Weight Management Program for Morbidly Obese Patients | Dr. WONG Simon Kin Hung |
2008.485 | Assessment of Efficacy and Tolerability of Prolonged Release Nicotinic Acid in Hong Kong Patients with Dyslipidaemia | Prof Tomlinson Brian |
2008.480 | Clinical Bioequivalence Study on Two Tramadol Formulations | Professor Lee Hon-leung, Vincent |
2008.479 | A Randomized Phase I/II, Multi-Center, Open-Label Trial of PR104 and Sorafenib in Patients with Advanced Hepatocellular Carcinoma | Dr. Chan Stephen Lam |
2008.470 | A Phase II, Open-Label, Cross-Sectional, Study to Compare eZscan, with Standard Methods of Screening for Diabetic Nephropathy, As a Tool for Detection of Type 2 Diabetic Nephropathy | Dr. Ozaki Risa |
2008.466 | Comparison of Oral Prednisolone and Oral Indomethacin in the Treatment of Acute Gout-like Arthritis: A Multi-centre, Double-Blind, Randomized Trial | Dr. Cheng Chi Hung |
2008.460 | An Experimental Study on the Effects of Manual Pressure in Pain Relief among Neonates During Heel Prick | Dr. Tse Mimi |
2008.459 | A Randomized Control Trial on the Effect of Whole Body Vibration Therapy in the Recruitment of Quadriceps Muscle Power in the Early Stage of Rehabilitation after Anterior Cruciate Ligament Reconstructive Surgery | Mr HO Ming Chiu Gilbert |
2008.455 | Exercise Compliance of Group and Home-based Tai Chi in Elderly Subjects: A Randomized Controlled Trial | Miss Lau Ka Yan Amy |
2008.448 | Mind-Body Intervention for Patients with Depression | Prof Chan Agnes S.Y. |
2008.445 | Low Glycemic Index Dietary Intervention Program in Nonalcoholic Fatty Liver Disease | Dr Wong Wai Sun |
2008.442 | A Comprehensive Care Programme for Patients with Chronic Obstructive Pulmonary Disease | Dr. Ko Wai-san Fanny |
2008.423 | Pilot Study of Efficacy and Safety of Chinese Herbal Medicine Gualou (Fructus Trichosanthis) in Treating Beta-thalassaemia Intermedia Patients | Prof Li Chi Kong |
2008.421 | The Effect of A Herbal Nose Drop on the Behavioral Problems of Individuals with Brain Dysfunction: A Pilot Study | Prof. CHAN Agnes Sui-yin |
2008.419 | Direct Percutaneous Baha Surgery (The Hong Kong Incision) | Dr. SOO Gordon |
2008.418 | Multicenter, Randomized, Double-Blind, Phase III Trial to Investigate the Efficacy and Safety of Oral BIBF 1120 Plus Standard Pemetrexed Therapy Compared to Placebo Plus Standard Pemetrexed Therapy in Patients with Stage IIIB/IV or Recurrent Non Small Cell Lung Cancer After Failure of First Line Chemotherapy | Prof. Lam Kwok Chi |
2008.417 | An Asia Pacific Non-Randomized, Open-Label Phase II Study Evaluating the Safety and Efficacy of FOLFIRI Plus Cetuximab (Erbitux) or FOLFOX Plus Cetuximab as First-Line Therapy in Subjects with KRAS Wild-Type Metastatic Colorectal Cancer (APEC-Study) | Prof. MA Brigette |
2008.416 | A 12-week Treatment, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Indacaterol (150 and 300 ug o.d.) in Patients with Chronic Obstructive Pulmonary Disease (COPD) | Prof. Hui Shu Cheong |
2008.414 | A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Carisbamate as Adjunctive Therapy in Subjects with Partial Onset Seizures, Followed by an Open-Label Extension Study | Prof. Kwan Patrick |
2008.413 | A Worldwide, Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose Ranging Study to Evaluate the Efficacy, Safety, and Tolerability of MK-0736 When Added to Ongoing Therapy With Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) in Patients With Diabetes and Hypertension | Dr. Chow Chun-chung Francis |
2008.405 | A Double-Blind Randomized Placebo Controlled Trial of Rabeprazole for Prevention of NSAID Associated Dyspepsia and Gastroduodenal Injury (RAN Study) | Prof Chan Francis KL |
2008.402 | A Pilot and Feasibility Study to Evaluate Capsule Endoscopy in Subjects Presenting with Acute, Overt Upper Gastrointestinal Hemorrhage | Prof. Sung Joseph |
2008.399 | A Phase 2, Open Label, Trial of PF-00299804 in Selected Patients with Untreated Advanced Adenocarcinoma of the Lung | PROF. MOK TONY S.K. |
2008.396 | Clinical Bioequivalence Study on Two Midazolam Formulations | Professor Lee Hon-leung, Vincent |
2008.395 | Phase I/II Study of Temsirolimus (Torisel) as Novel Therapeutic Drug for Patients with Unresectable Hepatocellular Carcinoma (HCC) - A Correlative Study with Stathmin Over-expression | Prof. YEO Winnie |
2008.391 | A Multi-Center, Continuation Trial of Belimumab (HGS1006, LymphoStat-B™), A Fully Human Monoclonal Anti-BLyS Antibody, in Subjects with Systemic Lupus Erythematosus (SLE) who Completed the Phase 3 Protocol HGS1006-C1056 or HGS1006-C1057 | Prof. TAM Lai Shan |
2008.388 | Effect of Cognitive Exercises on the Prevention of Cognitive Decline: A Randomized Controlled Trial | Prof. Kwok Timothy |
2008.384 | A Randomised, Double-blind, Parallel-group Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of Desmoteplase in Subjects with Acute Ischemic Stroke | Dr. LEUNG Thomas W.H. |
2008.383 | A Multi-Center, Randomized, Open-Label, Active-Controlled Study to Compare the Efficacy, Safety and Tolerability of Taspoglutide (RO5073031) versus Insulin Glargine in Insulin-Naive Type 2 Diabetic Patients Inadequately Controlled with Metformin and Sulphonylurea Combination Therapy | Prof. Kong Alice Pik-Shan |
2008.382 | An Open-Label Extension Phase of the Double-Blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Studies to Evaluate the Efficacy and Safety of E2007 (perampanel) Given as Adjunctive Therapy in Subjects with Refractory Partial Seizures | Dr Kwan Patrick |
2008.380 | Feasibility Study on Use of BreathID to Evaluate the Dynamic Liver Function of Patients with Chronic Hepatitis B | Prof Henry Lik-Yuen Chan |
2008.375 | Randomized Study of Pessary versus Expectant Management Among Women with A Short Cervix in Singleton Pregnancy | Dr Hui Shuk Yi Annie |
2008.374 | A Safety and Efficacy Trial Evaluating the Use of Apixaban for the extended Treatment of Deep Vein Thrombosis and Pulmonary Embolism | Prof. Lam Yat Yin |
2008.373 | A Safety and Efficacy Trial Evaluating the Use of Apixaban in the Treatment of Symptomatic Deep Vein Thrombosis and Pulmonary Embolism | Prof Yip Gabriel |
2008.372 | Feature Assessment Study for Indications Based Programming (FASt-IBP) | Dr. Fung Wing Hong |
2008.371 | Clinical Bioequivalence Study on Two Alprazolam Formulations | Professor Lee Hon-leung, Vincent |
2008.370 | Sequential Intravitreal Becavizumab, External Fluid Gas Exchange and Panretinal Photocoagulation in the Management of Post | Dr. Lee Yau Wing, Vincent |
2008.366 | Open-Label Extension Study of 23 mg Donepezil SR in Patients with Moderate to Severe Alzheimer | Prof. Mok C.T. Vincent |
2008.364 | Phase 3b, Randomized, Open-Label Study of Bevacizumab + Temsirolimus vs. Bevacizumab + Interferon-Alfa as First-line Treatment in Subjects with Advanced Renal Cell Carcinoma | Dr. Ho Wing Ming |
Page 233 of 254.